Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/04/2001WO2001072802A1 A new polypeptide-human amyloid precursor protein-binding protein 14 and the polynucleotide encoding it
10/04/2001WO2001072801A1 A novel polypeptide - human ribosomal s11 protein 12 and a polynucleotide sequence encoding the same
10/04/2001WO2001072800A1 A new polypeptide- human nuclear transforming protein 13 containing atp/gtp binding domain and the polynucleotide encoding it
10/04/2001WO2001072799A1 A novel polypeptide, human zinc finger protein 9 and the polynucleotide encoding thereof
10/04/2001WO2001072797A1 A novel polypeptide, a human promoter binding factor 13 and the polynucleotide encoding the polypeptide
10/04/2001WO2001072796A1 A novel polypeptide, a human cell differentiation transcription factor 11 and the polynucleotide encoding the polypeptide
10/04/2001WO2001072795A1 A novel polypeptide, a human quinoprotein reductase 16 and the polynucleotide encoding the polypeptide
10/04/2001WO2001072794A1 A novel polypeptide-helicase 16 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072793A1 A novel polypeptide-human proteolytic enzyme regulatory protein 12 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072792A1 A novel polypeptide - homo ubiquitin-like protein 13 and polynucleotide encoding said polypeptide
10/04/2001WO2001072791A1 A novel polypeptide, a human triose-phosphate isomerase 11 and the polynucleotide encoding the polypeptide
10/04/2001WO2001072790A1 A novel polypeptide, a human l1 factor p40 protein 12 and the polynucleotide encoding the polypeptide
10/04/2001WO2001072789A1 A novel polypeptide, a human zinc finger protein 10 and the polynucleotide encoding the polypeptide
10/04/2001WO2001072788A1 A novel polypeptide-human pterin-molybdenum oxidoreductase 10 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072787A1 A novel polypeptide-human peroxidosome assembly factor 10 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072786A1 A novel polypeptide - tumor suppressor protein 63 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072785A1 A novel polypeptide-human helix-loop-helix protein 17 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072784A2 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
10/04/2001WO2001072783A2 Production of secreted proteins by recombinant eukaryotic cells
10/04/2001WO2001072781A2 Human genes and expression products
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072779A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072775A2 Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
10/04/2001WO2001072774A2 Cell cycle progression proteins
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072772A2 Calcium binding regulatory subunit
10/04/2001WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists
10/04/2001WO2001072768A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
10/04/2001WO2001072766A1 Quality control reagents for nucleic acid microarrays
10/04/2001WO2001072765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
10/04/2001WO2001072764A1 N?8- and c8¿-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotide hybridization
10/04/2001WO2001072424A1 Heating specimen carriers
10/04/2001WO2001072341A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
10/04/2001WO2001072340A1 Aids virus vaccine with the use of sendai virus vector
10/04/2001WO2001072336A1 Compounds for targeting
10/04/2001WO2001072332A1 Method of screening for transcriptional coregulatory proteins of transcription factors
10/04/2001WO2001072329A1 Compositions and methods for enhancing immunogenicity of antigens
10/04/2001WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells
10/04/2001WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders
10/04/2001WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/04/2001WO2001072294A2 Method of treating hepatitis delta viral infection
10/04/2001WO2001072283A1 Cationic liposomes
10/04/2001WO2001072132A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof
10/04/2001WO2001072119A2 Non-human animal model for growth deficiency and information processing or cognitive function defects and use thereof
10/04/2001WO2001048227A8 Method for production of proteins in host cells involving the use of chaperonins
10/04/2001WO2001044198A8 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001036627A3 Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
10/04/2001WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/04/2001WO2001032685A3 Gene expression directed by a super-psa promoter
10/04/2001WO2001030970A3 Improved protocol for activation of oocytes
10/04/2001WO2001027256A9 Chimeric transcriptional regulatory element and methods for prostate-targeted gene expression
10/04/2001WO2001023563A3 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
10/04/2001WO2001022990A3 Methods related to immunostimulatory nucleic acid-induced interferon
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001021773A3 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
10/04/2001WO2001021644A3 Wheat dp proteins and uses thereof
10/04/2001WO2001019955A3 Lysosomal targeting pathway enzymes
10/04/2001WO2001019862A3 Polypeptides from moraxella (branhamella) catarrhalis
10/04/2001WO2001018208A3 Interferon induced polynucleotides and proteins encoded thereby
10/04/2001WO2001018058A3 Enhanced phage display library of human vh fragments and methods for producing same
10/04/2001WO2001016369A3 Uv excitable fluorescent energy transfer dyes
10/04/2001WO2001016334A3 Human hydrolytic enzymes
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001012800A3 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds
10/04/2001WO2001011047A3 Dna sequences isolated from human colonic epithelial cells
10/04/2001WO2001009312A3 Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets
10/04/2001WO2001008701A3 Invasive bacteria based viral vaccines
10/04/2001WO2001004361A3 Detection of hiv-1 by nucleic acid amplification
10/04/2001WO2001004135A3 Crosslinked dna condensate compositions and gene delivery methods
10/04/2001WO2001000663A3 Catalytically active recombinant memapsin and methods of use thereof
10/04/2001WO2001000244A3 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
10/04/2001WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
10/04/2001WO2000058351A3 ZWITTERMICIN A BIOSYNTHETIC GENE FROM $i(BACILLUS CEREUS)
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001WO2000046377A9 Genetically engineered retroviral vector particles capable of infecting non-dividing cells
10/04/2001WO2000046355A9 Telomerase reverse transcriptase transcriptional regulatory sequences
10/04/2001WO2000045839A3 A method for selecting and producing vaccine and diagnostic preparations
10/04/2001WO2000044935A3 Multiplex real-time pcr
10/04/2001WO2000043515A3 Methods of monitoring hiv drug resistance
10/04/2001WO2000042189A9 Interleukin-20
10/04/2001WO2000040695A9 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001WO2000032634A9 Humanized antibodies to gamma-interferon
10/04/2001WO2000017655A9 Water-soluble fluorescent semiconductor nanocrystals
10/04/2001WO2000017327A9 Terpene synthases
10/04/2001WO2000012708A3 Further pro polypeptides and sequences thereof
10/04/2001WO2000007018A3 Three-hybrid screening method for ligand-protein interactions
10/04/2001WO1999055860A8 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
10/04/2001WO1999046387A9 Biosynthetic genes for spinosyn insecticide production
10/04/2001US20010027569 Method of fertilizing an avian egg in the shell
10/04/2001US20010027568 Animal model for spinocerebellar ataxia and neurodegenerative diseases; transgene for polypeptide having polyglutamine tract; use screening for therapeutic agents
10/04/2001US20010027567 DNA molecule encoding recombinatorial substrate and reporter gene; activation by recombinase to effect gain or loss of gene function; transgenic mammal with said DNA; identification of transgene by phenotype of reporter gene
10/04/2001US20010027566 Transgenic animal model of basal cell carcinoma
10/04/2001US20010027565 Capable of binding envelope protein of hepatitis virus; therapy and/or diagnostic tool for hepatitis infection
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010027183 Polypeptides and polynucleotides of the thymidylate kinase family (tdk); screening for antibiotics
10/04/2001US20010027182 Spinocerebellar ataxia type 1 (SCA1); using chaperone proteins to aid in recognition/hydrolysis of mutant ataxin-1 by the proteasome; treating Alzheimer's, Parkinson's, prion disorders, dentatorubral-pallidoluysian atrophy and SCA1
1 ... 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 ... 4023